Feasibility of telephone follow-up after medical abortion
- PMID: 20103453
- DOI: 10.1016/j.contraception.2009.08.008
Feasibility of telephone follow-up after medical abortion
Abstract
Background: This study was conducted to assess the feasibility of using telephone calls combined with high-sensitivity urine pregnancy testing as a primary method of follow-up after medical abortion.
Methods: We enrolled 139 women up to 63 days of gestation to receive mifepristone 200 mg orally and misoprostol 800 mcg vaginally or buccally, per their choice. Participants were contacted by phone one week after mifepristone administration and interviewed using standardized questions. If the subject or clinician thought the pregnancy was not expelled, the subject returned for an ultrasound examination. Otherwise, subjects performed high-sensitivity home urine pregnancy testing 30 days after the mifepristone and were called within 3 days of the test. Those with positive pregnancy tests returned for an ultrasound examination. Those with negative tests required no further follow-up.
Results: Six of the 139 (4.3%, 95% CI 1.6-9.1%) subjects presented prior to Phone Call 1 for an in-person visit. All 133 (100%, 95% CI 97.8-100%) subjects eligible for their first telephone follow-up were contacted. Eight of the 133 (6.1%, 95% CI 2.6-11.5%) women were asked to return for evaluation and all did so (100%, 95% CI 63.1-100%). Eight of the 133 women eligible for the 30 day phone call presented for an interim visit prior to the call. After 30 days, 116 of the 117 (99.1%, 95% CI 97.5-100%) eligible subjects were contacted. One subject was not reached for the day 30 phone call. Twenty-seven of the 116 (23.3%, 95% CI 15.6-31.0%) subjects had a positive pregnancy test and required follow-up. Two of these subjects (7.4%, 95% CI 1.0-24.2%) did not return for in-person follow-up. Two of the 116 (1.7%, 95% CI 0.2-6.1%) subjects had inconclusive pregnancy tests and were asked to return for follow-up. One of these subjects (50%, 95% CI 1.2-98.7%) did not return. Complete follow-up was achieved in 135 of the 139 subjects (97.1%, 95% CI 94.3-99.9%). None of the 26 women evaluated for a positive or inconclusive pregnancy test had a gestational sac or continuing pregnancy.
Conclusion: Telephone follow-up combined with urine pregnancy testing after medical abortion is a feasible alternative to routine ultrasonography or serial serum hCG measurements.
Similar articles
-
Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol.BJOG. 2007 Feb;114(2):207-15. doi: 10.1111/j.1471-0528.2006.01179.x. BJOG. 2007. PMID: 17305893 Clinical Trial.
-
Ability of the clinician and patient to predict the outcome of mifepristone and misoprostol medical abortion.Contraception. 2004 Oct;70(4):313-7. doi: 10.1016/j.contraception.2004.04.005. Contraception. 2004. PMID: 15451336 Clinical Trial.
-
Mifepristone and misoprostol administered simultaneously versus 24 hours apart for abortion: a randomized controlled trial.Obstet Gynecol. 2007 Apr;109(4):885-94. doi: 10.1097/01.AOG.0000258298.35143.d2. Obstet Gynecol. 2007. PMID: 17400850 Clinical Trial.
-
Follow-up strategies to confirm the success of medical abortion of pregnancies up to 10 weeks' gestation: a systematic review with meta-analyses.Am J Obstet Gynecol. 2020 Jun;222(6):551-563.e13. doi: 10.1016/j.ajog.2019.11.1244. Epub 2019 Nov 9. Am J Obstet Gynecol. 2020. PMID: 31715147
-
Early pregnancy loss medical management in clinical practice.Contraception. 2023 Oct;126:110134. doi: 10.1016/j.contraception.2023.110134. Epub 2023 Jul 29. Contraception. 2023. PMID: 37524147 Review.
Cited by
-
A harm-reduction model of abortion counseling about misoprostol use in Peru with telephone and in-person follow-up: A cohort study.PLoS One. 2018 Jan 10;13(1):e0189195. doi: 10.1371/journal.pone.0189195. eCollection 2018. PLoS One. 2018. PMID: 29320513 Free PMC article.
-
Diagnosis and management of early pregnancy loss.CMAJ. 2024 Oct 14;196(34):E1162-E1168. doi: 10.1503/cmaj.231489. CMAJ. 2024. PMID: 39406415 Free PMC article. Review. No abstract available.
-
Management of first trimester pregnancy loss can be safely moved into the office.Rev Obstet Gynecol. 2011;4(1):5-14. Rev Obstet Gynecol. 2011. PMID: 21629493 Free PMC article.
-
Changes to medication abortion clinical practices in response to the COVID-19 pandemic.Contraception. 2021 Jul;104(1):77-81. doi: 10.1016/j.contraception.2021.04.010. Epub 2021 Apr 21. Contraception. 2021. PMID: 33894247 Free PMC article.
-
Simplified follow-up after medical abortion using a low-sensitivity urinary pregnancy test and a pictorial instruction sheet in Rajasthan, India--study protocol and intervention adaptation of a randomised control trial.BMC Womens Health. 2014 Aug 15;14:98. doi: 10.1186/1472-6874-14-98. BMC Womens Health. 2014. PMID: 25127545 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous